Hospital De La Santa Creu I Sant Pau
- Address
- Carrer De San Quinti 89, 08041 Barcelona, Spain
Neoplasms
The Hospital De La Santa Creu I Sant Pau conducts cutting‑edge research on neoplasms, focusing on solid tumors and hematologic malignancies across the Barcelona region.
- Advanced colorectal cancer with BRAF V600E mutation
- Early ER+/HER2‑ negative breast cancer
- Metastatic squamous non‑small cell lung cancer
- Relapsed or refractory diffuse large B‑cell lymphoma
A total of 13 clinical trials involve 186 investigators, advancing therapeutic options for cancer patients.
Nervous System Diseases
Within the department of Neurology, the site explores treatments for neurodegenerative and headache disorders, aiming to improve quality of life for affected individuals.
- Gene‑silencing therapy for Huntington’s disease
- Pediatric acute migraine management with novel agents
- Long‑term safety assessments in chronic neurological conditions
Ongoing studies leverage the expertise of 186 investigators to evaluate efficacy and safety in the nervous system field.
Immune System Diseases
Research in immune system diseases targets autoimmune skin conditions, employing innovative immunomodulatory approaches to reduce disease burden.
- Subacute and chronic cutaneous lupus erythematosus
- Severe alopecia areata in adults and adolescents
- Evaluation of novel biologics for refractory autoimmune disease
The department’s 13 trials aim to expand therapeutic options for patients with challenging immune‑mediated disorders.
Respiratory Tract Diseases
The site’s work on respiratory tract diseases integrates oncology and pulmonary health, seeking to improve outcomes for lung‑related malignancies.
- Immunotherapy comparison in metastatic squamous non‑small cell lung cancer
- Respiratory physiological monitoring within cancer trials
Clinical investigations combine oncology expertise with respiratory assessments to refine treatment strategies.
Digestive System Diseases
Studies in digestive system diseases concentrate on colorectal cancer, exploring targeted regimens that enable curative surgical interventions.
- Induction therapy for BRAF‑mutated advanced colorectal cancer
- Surgical feasibility after neoadjuvant targeted treatment
These trials contribute to multidisciplinary care pathways for patients with gastrointestinal malignancies.
Congenital, Hereditary, and Neonatal Diseases
The department supports investigations into congenital and hereditary conditions, emphasizing early detection and genetic counseling to guide preventive strategies.
- Genetic screening for hereditary cancer predisposition
- Neonatal neurological assessments linked to long‑term outcomes
Collaborative efforts with genetics specialists aim to integrate precision medicine from birth onward.
Circulatory and Respiratory Physiological Phenomena
Research on circulatory and respiratory physiological phenomena underpins many therapeutic trials, providing biomarkers that inform treatment response.
- Circulatory biomarker analysis in oncology studies
- Respiratory function evaluation during lung cancer therapy
These physiological insights enhance the safety and effectiveness of interventions across multiple disease areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 40 therapeutic areas and 15 of 814 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 770 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 176 by active trials.
lock +175 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB40trials
lock +94 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital De La Santa Creu I Sant Pau
lock Showing 1 of 735 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (20321) An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer sponsored studies | Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 814 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 48 | Unknown | 2015-05-05 | 2026-06-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.